Characterization of the Gut and Skin Microbiome over Time in Young Children with IgE-Mediated Food AllergyOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This pilot cohort study characterized the gut and skin microbiome over time in young children with IgE-mediated food allergy. Stool samples and skin swabs from forearm and elbow were collected at enrollment and at one-year follow-up. The bacterial 16S rRNA gene (v1-v2 region) was sequenced. Analyses compared allergic children with controls, tracked change over time, contrasted allergy types, and correlated taxa with total IgE.
Who was studied?
The study enrolled 23 children under 2 years with newly diagnosed IgE-mediated food allergy, drawn from an ongoing Swiss multicenter cohort. Median age was 12 months at enrollment and 24 months at follow-up. Fifteen children (65 percent) had tree nut and/or peanut allergy. The comparison group was 8 age-matched children without any allergy or atopic disease, recruited in Germany. Most allergic children had mild atopic dermatitis managed with emollients.
What were the most important findings?
Gut and skin bacterial diversity was significantly higher in allergic children than controls and rose over one year (betta test, Shannon, p below 0.01). Community composition differed significantly by time point and by allergy type (PERMANOVA p below 0.01). Firmicutes and Bacteroidota dominated the gut. High total IgE (above 100 kIU/mL) correlated with higher Collinsella in gut and skin among children with three or more allergies or sensitizations, and Collinsella was elevated in tree nut and/or peanut allergy.
What are the greatest implications of this study?
The study suggests the microbiome evolves alongside the developing child and differs by food allergy type, hinting that different allergies may have distinct underlying mechanisms. Collinsella emerges as a candidate biomarker for tree nut and/or peanut allergy, which tend to persist. Because the sample was only 23 patients and 8 controls with two time points, findings are preliminary. The counterintuitive rise in a short-chain-fatty-acid producer needs larger studies and metabolic work before Collinsella can be used clinically.